PRICE T ROWE ASSOCIATES INC /MD/ - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 193 filers reported holding CARDLYTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$378
+98.9%
22,907
-23.6%
0.00%
Q2 2023$190
+91.9%
29,982
+3.5%
0.00%
Q1 2023$99
-23.3%
28,977
+29.5%
0.00%
Q4 2022$129
-99.9%
22,377
-1.6%
0.00%
Q3 2022$214,000
-45.4%
22,750
+29.4%
0.00%
Q2 2022$392,000
-56.5%
17,580
+7.2%
0.00%
Q1 2022$901,000
-10.9%
16,396
+7.1%
0.00%
Q4 2021$1,011,000
-23.6%
15,304
-2.9%
0.00%
Q3 2021$1,324,000
-29.6%
15,768
+6.4%
0.00%
Q2 2021$1,881,000
+12.5%
14,823
-2.8%
0.00%
Q1 2021$1,672,000
-7.9%
15,246
+19.9%
0.00%
Q4 2020$1,816,000
+173.1%
12,718
+35.0%
0.00%
Q3 2020$665,000
-11.2%
9,419
-12.0%
0.00%
Q2 2020$749,000
-32.8%
10,698
-84.1%
0.00%
Q1 2019$1,114,000
+167.1%
67,379
+74.9%
0.00%
Q4 2018$417,000
-91.3%
38,533
-80.0%
0.00%
-100.0%
Q3 2018$4,817,000192,3800.00%
Other shareholders
CARDLYTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 5,416,116$89,365,91411.46%
KPS Global Asset Management UK Ltd 1,218,830$20,110,69510.97%
WORLDLY PARTNERS MANAGEMENT, LLC 996,881$16,448,53710.50%
General Equity Holdings LP 476,215$7,857,5489.59%
BERYLSON CAPITAL PARTNERS, LLC 195,000$3,217,5008.24%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 454,769$7,503,6895.27%
PB INVESTMENT PARTNERS, L.P. 343,061$5,660,5064.83%
VISA INC. 134,914$2,226,0812.50%
683 Capital Management, LLC 1,760,070$29,041,1562.26%
Antipodean Advisors LLC 20,000$330,0001.69%
View complete list of CARDLYTICS INC shareholders